As a biopharma company, we face challenging and evolving business and legal environments.
Conducting business in an ethical, sustainable and responsible way is fundamental to UCB’s core values. We have a strong culture of integrity, with policies and procedures in place to ensure the highest ethical standards are applied throughout the company’s value-chain, including the core principles governing how the organization operates, how decisions are made and how risk is mitigated.
The governance of UCB is based on a “one-tier” structure. This means that the Company is administrated by a Board of Directors and run by an Executive Committee, whose respective functions and responsibilities are clearly defined in accordance with the Articles of Association of the Company. The roles and responsibilities delegated to the Executive Committee are established by the Board.
The Board of Directors is UCB’s governing body.
The Board’s role is to pursue sustainable value creation by setting the company’s strategy and putting in place effective, entrepreneurial, responsible and ethical leadership within a framework of prudent and effective controls which enables risks to be assessed and managed. The Board sets UCB’s strategic aims, ensures that the necessary financial and human resources are in place for UCB to meet its objectives and monitors the company’s performance. The Board develops an inclusive approach that balances the legitimate interests and expectations of all stakeholders and sets UCB’s values and standards. It takes collegiate responsibility for sound exercise of its authority and powers. The Board ensures that the Company’s culture is supportive of the realization of its strategy and that it promotes responsible and ethical behavior.